Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (отвара нови прозор)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Извор‎: Pediatr Transplant 2017;21(6):e13017.

Индекс‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (отвара нови прозор)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (отвара нови прозор)

Bhatia M, Davenport V, Cairo MS.

Извор‎: Leuk Lymphoma 2007;48(1):9-15.

Индекс‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (отвара нови прозор)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (отвара нови прозор)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Извор‎: Lancet 2003;361(9354):275-80.

Индекс‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (отвара нови прозор)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (отвара нови прозор)

Fassel H, Bussel JB, Roberts SS, Modak S

Извор‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Индекс‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (отвара нови прозор)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (отвара нови прозор)

Jacobson AE, Shah N, Setty BA

Извор‎: Pediatr Blood Cancer 2017;64(8):e26473.

Индекс‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (отвара нови прозор)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (отвара нови прозор)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Извор‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Индекс‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (отвара нови прозор)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (отвара нови прозор)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Извор‎: Int J Hematol 2015;102(5):626-32.

Индекс‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (отвара нови прозор)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (отвара нови прозор)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Извор‎: J Pediatr 1996;129(5):656-60.

Индекс‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (отвара нови прозор)

Chemotherapy induced thrombocytopenia in pediatric oncology. (отвара нови прозор)

Tamamyan G, Danielyan S, Lambert MP

Извор‎: Crit Rev Oncol Hematol 2016;99:299-307.

Индекс‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (отвара нови прозор)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (отвара нови прозор)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Извор‎: Onkologie 2004;27(2):131-7.

Индекс‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (отвара нови прозор)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (отвара нови прозор)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Извор‎: Ann Oncol 2005;16(1):139-45.

Индекс‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (отвара нови прозор)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (отвара нови прозор)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Извор‎: Blood 1998;91(10):3601-6.

Индекс‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (отвара нови прозор)